Advertisement

Abstract

In the classic sense of carcinogenesis, such as that produced by ionizing radiation or “carcinogenic” hydrocarbons, hormones are probably not carcinogenic. They are either procarcinogens or cocarcinogens. In this sense, they produce more substrate either for initiation or for promotion by other substances, but of themselves they are probably not carcinogens. In the intact organism, the effects of administration of various hormones at crucial periods of the host’s life cycle may result in carcinogenic effects because of profound lifelong changes in endocrine balance that can be induced by a single hormone administration. This latter phenomenon might be referred to as the inducement of unfavorable hormonal imbalance, and this imbalance has a procarcinogenic effect.

Keywords

Breast Cancer Mammary Gland Anorexia Nervosa Corpus Luteum Pituitary Hormone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    A. Lacassagne, Apparition de cancer de la mamelle chez la souris male, soumise des injections de folliculine, C. R. Acad. Sei. Paris 195, 630–632 (1932).Google Scholar
  2. 2.
    J. Staats, The laboratory mouse, in: Biology of the Laboratory Mouse (E. L. Green, ed.), 2nd Ed., p. 1, McGraw-Hill, New York (1966).Google Scholar
  3. 3.
    J. J. Bittner, Tumor incidence in reciprocal F1 hybrid mice: A × D high tumor stocks, Proc. Soc. Exp. Biol. Med 34, 42–44 (1936).CrossRefGoogle Scholar
  4. 4.
    J.J. Bittner, Some possible effects of nursing on the mammary gland tumor incidence in mice, Science 84, 162–166 (1936).PubMedCrossRefGoogle Scholar
  5. 5.
    R. A. Huseby and J. J. Bittner, Studies on the inherited hormonal influence, Acta Unio Int. Contra Cancrum 6, 197–205 (1948).Google Scholar
  6. 6.
    L. T. Samuels and J. J. Bittner, Excretion of steroids in the feces of mice of various strains with and without the mammary tumor milk agent, 38th Annual Meeting of the American Association of Cancer Research (1947) (abstract).Google Scholar
  7. 7.
    R. A. Huseby, Personal communication, August 27 (1977).Google Scholar
  8. 8.
    B. Zondek, Tumor of pituitary induced with follicular hormone, Lancet 1 (April 4), 776–778 (1936).CrossRefGoogle Scholar
  9. 9.
    C. J. Shellabarger, in: Biology of Radiation Carcinogenesis (J. M. Yuhas, R. W. Pennant, and J. D. Reagan, eds.), pp. 31–43, Raven Press, New York (1976).Google Scholar
  10. 10.
    C. Huggins, L. C. Grand, and F. P. Brillantes, Mammary cancer induced by a single feeding of polynuclear hydrocarbons and its suppression, Nature (London) 189, 204–207 (1961).CrossRefGoogle Scholar
  11. 11.
    A. C. Andersen, Parameters of mammary gland tumors in aging beagles, J. Am. Vet. Med. Assoc 147, 1653–1654 (1965).Google Scholar
  12. 12.
    R. Tyslowitz and E. Dingemanse, Effect of large doses of estrogens on the blood picture of dogs, Endocrinology 29, 817–827 (1941).CrossRefGoogle Scholar
  13. 13.
    R. Hill and K. Dumas, The use of dogs for studies of toxicity of contraceptive hormones, in: Pharmacological Models in Contraceptive Developments, p. 74, World Health Organization, Stockholm (1974).Google Scholar
  14. 14.
    V. A. Drill, D. P. Martin, and E. R. Hart, Effect of oral contraceptives on the mammary glands of rhesus monkeys: A preliminary report, J. Natl. Cancer Inst 52, 1655–1657 (1974).PubMedGoogle Scholar
  15. 15.
    R. L. Kirschstein, A. S. Rabson, and G. W. Rusten, Infiltrating duct carcinoma of the mammary gland of a rhesus monkey after administration of an oral contraceptive: A preliminary report, J. Natl. Cancer Inst 48, 551–556 (1972).PubMedGoogle Scholar
  16. 16.
    R. Hoover, L. A. Gray, Sr, P. Cole, et al., Menopausal estrogens and breast cancer, New Engl. J. Med 295, 401–405 (1976).PubMedCrossRefGoogle Scholar
  17. 17.
    E. M. Glenn, S. L. Richardson, and B. J. Bowman, A method of assay of antitumor activity using a rat mammary fibroadenoma, Endocrinology 64, 379–389 (1959).PubMedCrossRefGoogle Scholar
  18. 18.
    W. O. Nelson, The induction of mammary carcinoma in the rat, Yale J. Biol. Med 17, 217–228 (1944).PubMedPubMedCentralGoogle Scholar
  19. 19.
    C. S. McEuen, Occurrence of cancer in rats treated with oestrone, Am J. Cancer 34, 184–195 (1938).PubMedGoogle Scholar
  20. 20.
    C.F. Geschicter, Diseases of the Breast, J. B. Lippincott, Philadelphia (1943).Google Scholar
  21. 21.
    R. L. Noble, C. S. McEuen, and J. B. Collip, Mammary tumours produced in rats by the action of oestrone tablets, Can. Med. Assoc. J 42, 413–417 (1940).PubMedPubMedCentralGoogle Scholar
  22. 22.
    R. L. Noble, A new approach to the hormonal cause and control of experimental carcinomas including those of the breast, Ann. R. Coll. Physicians Surg. Can 9, 169–180 (1976).Google Scholar
  23. 23.
    A. Segaloff and H. Pettigrew, Effect of radiation dosage on the synergism between radiation and estrogen in the production of mammary cancer in the rat Cancer Res (in press).Google Scholar
  24. 24.
    A. Segaloff, Inhibition by progesterone of radiation-estrogen-induced mammary cancer in the rat, Cancer Res 33, 1136–1137 (1973).PubMedGoogle Scholar
  25. 25.
    J. H. Cutts, Estrogen-induced breast cancer in the rat, Sixth Canadian Cancer Conference, London (1966), p. 50.Google Scholar
  26. 26.
    F. Schiotzhe and J. K. McDonald, Relaxin: A disulfide homolog of insulin, Science 197, 914–915 (1977).CrossRefGoogle Scholar
  27. 27.
    E. M. O’Byrne and B. G. Steinetz, Radioimmunoassay (RIA) of relaxin in sera of various species using an antiserum to porcine relaxin, Proc. Soc. Exp. Biol. Med 152, 272–276 (1976).PubMedCrossRefGoogle Scholar
  28. 28.
    E. M. O’Byrne, B. T. Carriere, L. Sorensen, A. Segaloff, C. Schwabe, and B. G. Steinetz, Plasma immunoreactive relaxin levels in pregnant and non-pregnant women, J. Clin. Endocrinol. Metab (in press) (1978).Google Scholar
  29. 29.
    J. H. Clark, Z. Paszko, and E. J. Peck Jr., Nuclear binding and retention of the receptor estrogen complex: Relation to the agonistic and antagonistic properties of estriol, Endocrinology 100, 91–96 (1977).PubMedCrossRefGoogle Scholar
  30. 30.
    B. G. Miller, The relative potencies of oestriol, oestradiol and oestrone on the uterus and vagina of the mouse, J. Endocrinol 43, 563–570 (1969).PubMedCrossRefGoogle Scholar
  31. 31.
    C. W. Emmens and L. Martin, Estrogens, in: Methods in Hormone Research (R. I. Dorfman, ed.), Vol. 3, pp. 1–80, Academic Press, New York (1964).Google Scholar
  32. 32.
    R. L. Noble, Hormonal control of growth and progression in tumors of Nb rats and a theory of action, Cancer Res 37, 82–94 (1977).PubMedGoogle Scholar
  33. 33.
    G. V. Rudali, F. Apiou, and B. Muel, Mammary cancer produced in mice with estriol, Eur. J. Cancer 11, 39–41 (1975).PubMedCrossRefGoogle Scholar
  34. 34.
    H. A. Bern, The neonatal mouse—Tumorigenesis after short-term exposure to hormones and its possible relevance to human syndrome, in: Proceedings: Symposium on Endocrine-Induced Neoplasia, Eppley Institute for Research in Cancer, Omaha, Nebraska (1977).Google Scholar
  35. 35.
    A. Lipschutz, Steroid Hormones and Tumors, Williams and Wilkins, Baltimore (1950).Google Scholar
  36. 36.
    W. O. Nelson, Endometrial and myometrial changes, including fibromyomatous nodules, induced in the uterus of the guinea pig by the prolonged administration of oestrogenic hormone, Anat. Rec 68, 99–102 (1937).CrossRefGoogle Scholar
  37. 37.
    G. W. Beatson, On the treatment of inoperable cases of carcinoma of the mammary gland: Suggestions for a new method of treatment with illustrative cases, Lancet 2, 104, 162 (1896).CrossRefGoogle Scholar
  38. 38.
    R. M. O’Bryan, G. S. Gordan, R. M. Kelley, R. G. Ravdin, A. Segaloff, and S. Taylor, Does thyroid substance improve response of breast cancer to surgical castration?, Cancer 33, 1082–1085 (1974).PubMedCrossRefGoogle Scholar
  39. 39.
    C. C. Kapdi and J. N. Wolfe, Breast cancer: Relationship to thyroid supplements for hypothyroidism, J. Am. Med. Assoc 236, 1124–1127 (1976).CrossRefGoogle Scholar
  40. 40.
    I. Mittra and J. L. Hayward, Hypothalamic-pituitary-thyroid axis in breast cancer, Lancet 1 (May 11), 885–889 (1974).PubMedCrossRefGoogle Scholar
  41. 41.
    P. Mustacchi and F. Greenspan, Thyroid supplementation for hypothyroidism: An iatrogenic cause of breast cancer?, J. Am. Med. Assoc 237, 1446–1447 (1977).CrossRefGoogle Scholar
  42. 42.
    American Thyroid Association, Breast cancer and thyroid therapy, J. Am. Med. Assoc 237, 1459–1460 (1977).CrossRefGoogle Scholar
  43. 43.
    J. Fishman, L. Hellman, B. Zumoff, and T. F. Gallagher, Influence of thyroid hormone on estrogen metabolism in man, J. Clin. Endocrinol. Metab 22, 389–392 (1962).PubMedCrossRefGoogle Scholar
  44. 44.
    J. Fishman, L. Hellman, B. Zumoff, and T. F. Gallagher, Effect of thyroid on hydroxy-lation of estrogen in man, J. Clin. Endocrinol. Metab 25, 365–368 (1965).PubMedCrossRefGoogle Scholar
  45. 45.
    J. Fishman, R. M. Boyar, and L. Hellman, Influence of body weight on estradiol metabolism in young women, J. Clin. Endocrinol. Metab 41, 989–991 (1975).PubMedCrossRefGoogle Scholar
  46. 46.
    A. Segaloff, The “sparing’’ effect of progesterone on the hepatic inactivation of alpha-estradiol, Endocrinology 40, 44–46 (1947).PubMedCrossRefGoogle Scholar
  47. 47.
    N. D. Cohen and R. Hilf, Influence of insulin on growth and metabolism of 7,12-dimethylbenz(a)anthracene induced mammary tumors, Cancer Res 34, 3245–3252 (1974).PubMedGoogle Scholar
  48. 48.
    B. M. Sherman and S. S. Korenman, Hormonal characteristics of the human menstrual cycle throughout reproductive life, J. Clin. Invest 55, 699–702 (1975).PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.
    M. Kodama, T. Kodama, S. Miura, and M. Yoshida, Hormonal status of breast cancer. III. Further analysis of ovarian, adrenal dysfunction, J. Natl. Cancer Inst 59, 49–54 (1977).PubMedGoogle Scholar
  50. 50.
    H. D. Moon, M. E. Simpson, C. H. Li, and H. M. Evans, Neoplasms in rats treated with pituitary growth hormone. III. Reproductive organs, Cancer Res 10, 549–556 (1950).PubMedGoogle Scholar
  51. 51.
    J. Meites, Relation of prolactin to mammary tumorigenesis and growth in rats, in: Tenovus Workshop, Fourth, Cardiff, Wales, Prolactin and Carcinogenesis (A. R. Boyns and K. Griffiths, eds.), pp. 54–63, Alpha Omega Alpha, Cardiff, Wales (1972).Google Scholar
  52. 52.
    J. Furth, The influence of hormones on initiation and the maintenance of tumorous growths by radiation and other carcinogens, in: Symposium on Tumorigenic and Genetic Effects of Radiation (G. Woalinder, ed.), pp. 57–106, National Swedish Environment Protection Board, Solna (1976).Google Scholar
  53. 53.
    K. Yokoro and J. Furth, Relation of mammotropes to mammary tumors. V. Role of mammotropes in radiation carcinogenesis, Proc. Soc. Exp. Biol. Med 107, 921–924 (1961).PubMedCrossRefGoogle Scholar
  54. 54.
    K. H. Clifton, B. N. Sridharan, and E. B. Dupole, Mammary carcinogenesis-enhancing effect of adrenalectomy in irradiated rats with pituitary tumor MtT-F 4, J. Natl. Cancer Inst 55, 485–487 (1975).PubMedGoogle Scholar
  55. 55.
    K. H. Clifton, E. B. Dupole, and B. N. Sridharan, Effects of graft of single anterior pituitary gland on the incidence and type of mammary neoplasm in neutron or gamma irradiated Fischer female rats, Cancer Res 36, 3732–3735 (1976).PubMedGoogle Scholar
  56. 56.
    R. D. Bulbrook, D. Y. Wang, and M. C. Swain, Prolactin and breast cancer, in: Tenovus Workshop, Fourth, Cardiff, Wales, Prolactin and Carcinogenesis (A. R. Boyns and K. Griffiths, eds.), pp. 143–148, Alpha Omega Alpha, Cardiff, Wales (1972).Google Scholar
  57. 57.
    C. W. Welsch and H. Nagasawa, Prolactin and murine mammary tumorigenesis: A review, Cancer Res 37, 951–963 (1977).PubMedGoogle Scholar
  58. 58.
    Po-Chueu Chan, J. F. Head, L. A. Cohen, and E. L. Wynder, Effect of high fat diet on serum prolactin levels and mammary cancer development in ovariectomized rats, 68th Annual Meeting of the American Association of Cancer Research, May (1977) (abstract #753).Google Scholar

Copyright information

© Springer Science+Business Media New York 1978

Authors and Affiliations

  • Albert Segaloff
    • 1
  1. 1.Section on Endocrine Research of the Richard W. Freeman Research InstituteAlton Ochsner Medical FoundationNew OrleansUSA

Personalised recommendations